| Description | Gemnelatinib (WO2018077227, implementation example 1) is a tyrosine kinase inhibitor with potential applications in cancer research. |
| In vitro | Gemnelatinib is a tyrosine kinase inhibitor[1] |
| molecular weight | 524.6 |
| Molecular formula | C30H29FN6O2 |
| CAS | 2225123-30-6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| References | 1. WO2018077227 |